CanadaBis Capital (CANB) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
25 Feb, 2026Executive summary
Achieved tenth consecutive quarter of net revenue, reflecting sustained profitability and operational momentum.
Strategic investments in innovation and brand awareness campaigns supported growth and market share expansion.
Enhanced operational efficiency through a 20% reduction in operational costs.
Expanded product portfolio with the launch of a 60% THC pre-roll and new SKUs.
Established a strategic partnership with a distribution company in Portugal to enhance international reach.
Financial highlights
Q3 2024 revenue reached $7.1 million, with net income of $3.97 million.
Adjusted EBITDA for the quarter was $5 million.
Operational costs decreased by 20%, contributing to improved margins.
Outlook and guidance
Plans to further diversify SKU portfolio and enhance product innovation.
Focus on strengthening market position domestically and internationally.
Management remains optimistic about growth opportunities as the cannabis sector expands globally.
Latest events from CanadaBis Capital
- FY2024 net income reached $600,285, driven by new products and operational efficiencies.CANB
Q4 202425 Feb 2026 - Record revenue and profitability achieved, driven by innovation and international expansion.CANB
Q1 202525 Feb 2026 - Q2 2025 gross revenue surged 29% to $9M, with adjusted EBITDA of $434K and net earnings of $96K.CANB
Q2 202525 Feb 2026 - Achieved positive adjusted EBITDA, improved margins, and strengthened liquidity despite market headwinds.CANB
Q3 202525 Feb 2026 - Gross profit and adjusted EBITDA fell despite stable revenue, with new strategies set for 2026 growth.CANB
Q4 202525 Feb 2026 - Positive cash flow and margin gains achieved despite revenue decline and market disruptions.CANB
Q1 202625 Feb 2026